Heparan-6-O-endosulfatase 2, a cancer-related proteoglycan enzyme, is effectively inhibited by a specific sea cucumber fucosylated glycosaminoglycan.

Fuente: PubMed
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Farrag, Marwa, Aljuhani, Reem, Benicky, Julius, Al Ahmed, Hoda, Misra, Sandeep K, Mishra, Sushil K, Sharp, Joshua S, Doerksen, Robert J, Goldman, Radoslav, Pomin, Vitor H
Format: Artículo científico
Langue:en
Publié: Glycobiology 2025
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1868266209170948098
author Farrag, Marwa
Aljuhani, Reem
Benicky, Julius
Al Ahmed, Hoda
Misra, Sandeep K
Mishra, Sushil K
Sharp, Joshua S
Doerksen, Robert J
Goldman, Radoslav
Pomin, Vitor H
author_facet Farrag, Marwa
Aljuhani, Reem
Benicky, Julius
Al Ahmed, Hoda
Misra, Sandeep K
Mishra, Sushil K
Sharp, Joshua S
Doerksen, Robert J
Goldman, Radoslav
Pomin, Vitor H
Farrag, Marwa
Aljuhani, Reem
Benicky, Julius
Al Ahmed, Hoda
Misra, Sandeep K
Mishra, Sushil K
Sharp, Joshua S
Doerksen, Robert J
Goldman, Radoslav
Pomin, Vitor H
collection PubMed - marine biology
contents Heparan-6-O-endosulfatase 2, a cancer-related proteoglycan enzyme, is effectively inhibited by a specific sea cucumber fucosylated glycosaminoglycan. Farrag, Marwa Aljuhani, Reem Benicky, Julius Al Ahmed, Hoda Misra, Sandeep K Mishra, Sushil K Sharp, Joshua S Doerksen, Robert J Goldman, Radoslav Pomin, Vitor H Animals Sulfotransferases Humans Sea Cucumbers Chondroitin Sulfates Enzyme Inhibitors Holothuria Glycosaminoglycans Sulfatases Heparan-6-O-endosulfatase 2 (Sulf-2) is a proteoglycan enzyme that modifies sulfation of heparan sulfate proteoglycans. Dysregulation of Sulf-2 is associated with various pathological conditions, including cancer, which makes Sulf-2 a potential therapeutic target. Despite the key pathophysiological roles of Sulf-2, inhibitors remain insufficiently developed. In previous work, a fucosylated chondroitin sulfate from the sea cucumber Holothuria floridana (HfFucCS) exhibited potent Sulf-2 inhibition. This study investigates the structural basis of HfFucCS-mediated Sulf-2 inhibition, examines the binding profile of HfFucCS to Sulf-2, and explores the mode of inhibition. Additionally, a structurally diverse library of sulfated poly/oligosaccharides, including common glycosaminoglycans and unique marine sulfated glycans, was screened for Sulf-2 inhibition. Results from a high-throughput arylsulfatase assay and specific 6-O-desulfation assay have proved that HfFucCS is the most potent among the tested sulfated glycans, likely due to the presence of the unique 3,4-disulfated fucose structural motif. HfFucCS demonstrated non-competitive inhibition, and inhibitory analysis of its low-molecular-weight fragments suggests a minimum length of ~7.5 kDa for effective inhibition. Surface plasmon resonance analyses revealed that Sulf-2 binds to surface heparin with high affinity (KD of 0.817 nM). HfFucCS and its derivatives effectively disrupt this interaction. Results from mass spectrometry-hydroxyl radical protein footprinting and repulsive scaling replica exchange molecular dynamics indicate similarities in the binding of heparin and HfFucCS oligosaccharides to both the catalytic and hydrophilic domains of Sulf-2. These findings reveal the unique inhibitory properties of a structurally distinct marine glycosaminoglycan, supporting its further investigation as a selective and effective inhibitor for Sulf-2-associated cancer events.
format Artículo científico
id pubmed_40302034
institution PubMed
language en
publishDate 2025
publisher Glycobiology
record_format pubmed
spellingShingle Heparan-6-O-endosulfatase 2, a cancer-related proteoglycan enzyme, is effectively inhibited by a specific sea cucumber fucosylated glycosaminoglycan.
Farrag, Marwa
Aljuhani, Reem
Benicky, Julius
Al Ahmed, Hoda
Misra, Sandeep K
Mishra, Sushil K
Sharp, Joshua S
Doerksen, Robert J
Goldman, Radoslav
Pomin, Vitor H
Animals
Sulfotransferases
Humans
Sea Cucumbers
Chondroitin Sulfates
Enzyme Inhibitors
Holothuria
Glycosaminoglycans
Sulfatases
Heparan-6-O-endosulfatase 2, a cancer-related proteoglycan enzyme, is effectively inhibited by a specific sea cucumber fucosylated glycosaminoglycan. Farrag, Marwa Aljuhani, Reem Benicky, Julius Al Ahmed, Hoda Misra, Sandeep K Mishra, Sushil K Sharp, Joshua S Doerksen, Robert J Goldman, Radoslav Pomin, Vitor H Animals Sulfotransferases Humans Sea Cucumbers Chondroitin Sulfates Enzyme Inhibitors Holothuria Glycosaminoglycans Sulfatases Heparan-6-O-endosulfatase 2 (Sulf-2) is a proteoglycan enzyme that modifies sulfation of heparan sulfate proteoglycans. Dysregulation of Sulf-2 is associated with various pathological conditions, including cancer, which makes Sulf-2 a potential therapeutic target. Despite the key pathophysiological roles of Sulf-2, inhibitors remain insufficiently developed. In previous work, a fucosylated chondroitin sulfate from the sea cucumber Holothuria floridana (HfFucCS) exhibited potent Sulf-2 inhibition. This study investigates the structural basis of HfFucCS-mediated Sulf-2 inhibition, examines the binding profile of HfFucCS to Sulf-2, and explores the mode of inhibition. Additionally, a structurally diverse library of sulfated poly/oligosaccharides, including common glycosaminoglycans and unique marine sulfated glycans, was screened for Sulf-2 inhibition. Results from a high-throughput arylsulfatase assay and specific 6-O-desulfation assay have proved that HfFucCS is the most potent among the tested sulfated glycans, likely due to the presence of the unique 3,4-disulfated fucose structural motif. HfFucCS demonstrated non-competitive inhibition, and inhibitory analysis of its low-molecular-weight fragments suggests a minimum length of ~7.5 kDa for effective inhibition. Surface plasmon resonance analyses revealed that Sulf-2 binds to surface heparin with high affinity (KD of 0.817 nM). HfFucCS and its derivatives effectively disrupt this interaction. Results from mass spectrometry-hydroxyl radical protein footprinting and repulsive scaling replica exchange molecular dynamics indicate similarities in the binding of heparin and HfFucCS oligosaccharides to both the catalytic and hydrophilic domains of Sulf-2. These findings reveal the unique inhibitory properties of a structurally distinct marine glycosaminoglycan, supporting its further investigation as a selective and effective inhibitor for Sulf-2-associated cancer events.
title Heparan-6-O-endosulfatase 2, a cancer-related proteoglycan enzyme, is effectively inhibited by a specific sea cucumber fucosylated glycosaminoglycan.
topic Animals
Sulfotransferases
Humans
Sea Cucumbers
Chondroitin Sulfates
Enzyme Inhibitors
Holothuria
Glycosaminoglycans
Sulfatases
url https://pubmed.ncbi.nlm.nih.gov/40302034/